derivative sub-AAV8-IP-02 AAV8-CG-IP-02 1 .xml (File)

Project:

OT2OD024912

Project (Entity type)

Id Namespace:

SPARC file namespace

Identifier Namespace (Entity type)

File Format:

image format

File Format (Entity type)

Dcc Asset:

C2M2 datapackage 202509.zip

Processed File (Entity type)

Dcc:

SPARC

DCC (Entity type)

Data Type:

gene expression profile

Data Type (Entity type)

Assay Type:

transcription profiling assay

Assay Type (Entity type)

Uncompressed Size In Bytes:137 KB

Size In Bytes:137 KB

Sha256:25a7de6e6403a8c95e57c37a6d39c3808bf30fbe3d71231d4e2dd4fff0637b15

Persistent Id:sparc.drs:package/24d55b59-0c75-479b-a7d2-19645b937514

Mime Type:image/tiff

Filename:derivative__sub-AAV8-IP-02__AAV8-CG-IP-02__1_.xml

Creation Time:2022-12-13T15:43:03+00:00

Access Url:

https://services.scicrunch.io/sparc/drs/v1/package/24d55b59-0c75-479b-a7d2-19645b937514

Results found

Linked to

	Label	Description
	N:dataset:fce3f57f-18ea-4453-887e-58a885e90e7e Collection (Entity type)	Assessment of AAV serotypes 6, 8 and 9 for targeting pancreatic innervation.
	N:dataset:fce3f57f-18ea-4453-887e-58a885e90e7e AAV8-IP-02 Subject (Entity type)	A subject from SPARC produced as part of the OT2OD024912 project
	N:dataset:fce3f57f-18ea-4453-887e-58a885e90e7e AAV8-IP-02 default Biosample (Entity type)	A biosample from SPARC produced as part of the OT2OD024912 project

N:dataset:fce3f57f-18ea-4453-887e-58a885e90e7e

Collection (Entity type)

Assessment of AAV serotypes 6, 8 and 9 for targeting pancreatic innervation.

N:dataset:fce3f57f-18ea-4453-887e-58a885e90e7e AAV8-IP-02

Subject (Entity type)

A subject from SPARC produced as part of the OT2OD024912 project

N:dataset:fce3f57f-18ea-4453-887e-58a885e90e7e AAV8-IP-02 default

Biosample (Entity type)

A biosample from SPARC produced as part of the OT2OD024912 project

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.